Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
- PMID: 30111217
- PMCID: PMC6166357
- DOI: 10.1177/0300060518789304
Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
Abstract
Objectives This study aimed to examine a simple, effective, time-saving, and low-cost protein microarray method for detecting serum alpha-fetoprotein (AFP) and AFP-L3 levels. Methods Serum samples from patients with hepatocellular carcinoma (HCC) (n = 33) and control subjects (n = 39) were collected and evaluated for the presence of AFP using a novel protein microarray. Glycoprotein (including AFP-L3) was enriched from crude samples by a Hotgen Biotech glycosyl capture spin column and then detected by protein microarray. An electrochemiluminescence immunoassay (ECLIA) was used to validate the measured values. Results Neither AFP levels lower than 20 ng/mL in the HCC group nor AFP levels higher than 20 ng/mL in the control group were found when tested by the ECLIA and protein microarray. The kappa test showed good consistency in the diagnostic performance of measuring serum AFP levels and the percentage of AFP-L3 in total AFP by the ECLIA and protein microarray. Protein microarray had advantages of smaller sample size required, low cost, and convenience compared with the ECLIA. Conclusion The protein microarray assay that was developed in the present study shows potential as an economic and convenient technique for detecting AFP and AFP-L3 levels in serum samples from patients with HCC.
Keywords: AFP-L3; Lens culinaris agglutinin; Protein microarray; alpha-fetoprotein (AFP); electrochemiluminescence immunoassay; glycoprotein; hepatocellular carcinoma.
Figures



Similar articles
-
Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.J Int Med Res. 2016 Dec;44(6):1414-1423. doi: 10.1177/0300060516672370. Epub 2016 Nov 24. J Int Med Res. 2016. PMID: 27885040 Free PMC article.
-
A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index.Sci Rep. 2016 Aug 16;6:31132. doi: 10.1038/srep31132. Sci Rep. 2016. PMID: 27528397 Free PMC article.
-
Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.Oncol Rep. 2011 Nov;26(5):1227-33. doi: 10.3892/or.2011.1425. Epub 2011 Aug 19. Oncol Rep. 2011. PMID: 21874252
-
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.Clin Liver Dis. 2015 May;19(2):309-23. doi: 10.1016/j.cld.2015.01.005. Epub 2015 Feb 27. Clin Liver Dis. 2015. PMID: 25921665 Review.
-
Highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein: a new tool for the management of hepatocellular carcinoma.Oncology. 2011;81 Suppl 1:61-5. doi: 10.1159/000333263. Epub 2011 Dec 22. Oncology. 2011. PMID: 22212938 Review.
Cited by
-
Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer.World J Clin Cases. 2022 Sep 16;10(26):9264-9275. doi: 10.12998/wjcc.v10.i26.9264. World J Clin Cases. 2022. PMID: 36159417 Free PMC article.
-
Reusable, Noninvasive, and Sensitive Fluorescence Enhanced ZnO-Nanorod-Based Microarrays for Quantitative Detection of AFP in Human Serum.Biomed Res Int. 2021 Jul 15;2021:9916909. doi: 10.1155/2021/9916909. eCollection 2021. Biomed Res Int. 2021. PMID: 34327239 Free PMC article.
-
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.BMC Cancer. 2024 Feb 21;24(1):239. doi: 10.1186/s12885-024-11984-6. BMC Cancer. 2024. PMID: 38383334 Free PMC article.
-
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.Metabolites. 2020 Jan 28;10(2):50. doi: 10.3390/metabo10020050. Metabolites. 2020. PMID: 32012846 Free PMC article. Review.
-
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers.Biosensors (Basel). 2023 Mar 18;13(3):398. doi: 10.3390/bios13030398. Biosensors (Basel). 2023. PMID: 36979610 Free PMC article. Review.
References
-
- Giunchi F, Vasuri F, Fiorentino M. Epidemiology of hepatocellular carcinoma. In: Loda M, Mucci L, Mittelstadt M, Van Hemelrijck M and Cotter M. (eds) Pathology and Epidemiology of Cancer Springer, Cham, 2017, pp.447–454. DOI: 10.1007/978-3-319-35153-7_23
-
- Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016; 64(1 Suppl): S84–S101. - PubMed
-
- Nagaratnam N, Nagaratnam K, Cheuk G. Hepatocellular carcinoma. In: Geriatric Diseases Cham: Springer, 2017, pp.1–4.
-
- Zhao Y, Wang M, Cui C, et al. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma. Cancer Biomarkers:Section A of Disease Markers 2015; 15: 677–683. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical